1002334-12-4

Basic information

• Product Name: 1-Phenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
• Synonyms: 1-Phenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole;1-phenyl-1H-pyrazole-4-boronic acid pinacol ester;1-Phenylpyrazole-4-boronic acid, pinacol ester;1H-Pyrazole, 1-phenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-;(1-PHENYL-1H-PYRAZOL-4-YL)BORONIC ACID PINACOL ESTER
• CAS NO: 1002334-12-4
• Molecular Formula: C₁₅H₁₉BN₂O₂
• Molecular Weight: 270.13456
• Mol File: 1002334-12-4.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 389.8±15.0 °C(Predicted)
• Appearance: /
• Density: 1.08±0.1 g/cm3(Predicted)
• Storage Temp.: Inert atmosphere,Store in freezer, under -20°C
• PKA: -0.58±0.10(Predicted)
• CAS DataBase Reference: 1-Phenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Phenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole(1002334-12-4)
• EPA Substance Registry System: 1-Phenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole(1002334-12-4)

Safety Data

• Hazardous Substances Data: 1002334-12-4(Hazardous Substances Data)

Usage

General Description

1-Phenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole is a chemical compound that contains a boron atom. It is commonly used in organic synthesis as a building block for the creation of various pharmaceuticals and agrochemicals. 1-Phenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole has a pyrazole backbone with a phenyl group at one end and a boron-containing dioxaborolane group at the other end. The presence of the boron atom makes it a useful reagent for Suzuki-Miyaura cross-coupling reactions, which are important in the formation of carbon-carbon bonds in organic synthesis. Additionally, the tetramethyl substitution on the dioxaborolane moiety makes it particularly stable and less reactive toward protodeboronation, increasing its utility as a synthetic reagent. Overall, 1-Phenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole is a valuable compound in organic synthesis due to its versatility and stability as a boron-containing reagent.

Upstream product

• 76-09-5 2,3-dimethyl-2,3-butane diol 
• 100-63-0 phenylhydrazine 
• 23889-85-2 4-iodo-1-phenyl 1H-pyrazole 
• 73183-34-3 bis(pinacol)diborane 
• 98-80-6 phenylboronic acid 
• 15115-52-3 4-bromo-1-phenyl-1H-pyrazole 
• 508191-77-3 3-phenylsydnone 
• 347389-74-6 2-ethynyl-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane 

Downstream Products

• 1201643-70-0 (1-phenyl-1H-pyrazol-4-yl)boronic acid 
• 1469884-07-8 C₂₁H₂₃N₇ 
• 1361297-64-4 2-methoxyethyl 4-(7-(bis((2-(trimethylsilyl)ethoxy)methyl)amino)-3-(1-phenyl-1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-5-yl)-1-(2-methoxyethoxy)cyclohexanecarboxylate 

Relevant articles and documents

Potent and orally bioavailable CDK8 inhibitors: Design, synthesis, structure-activity relationship analysis and biological evaluation

CDK8 regulates transcription either by phosphorylation of transcription factors or, as part of a four-subunit kinase module, through a reversible association of the kinase module with the Mediator complex, a highly conserved transcriptional coactivator. D

HETEROARYL COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF

The present invention provides herein is a heteroaryl compound or a stereoisomer, a geometric isomer, a tautomer, a racemate, an N-oxide, a hydrate, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, as well as a pharmaceutical composition containing the compound disclosed herein. The present invention also provides herein is use of the compound or the pharmaceutical composition thereof disclosed herein in the manufacture of a medicine for treating autoimmune diseases or proliferative diseases.

Investigation of the scope and regiochemistry of alkynylboronate cycloadditions with sydnones

The cycloaddition of alkynylboronates and sydnones provides a convenientand highly regioselective method for the synthesis of a broad range of di-, tri-, and tetrasubstituted pyrazole boronic esters. The origins of an observed regiochemical divergence in the reactions of terminal alkyny lboronates with their more substituted analogues have been studied by DFT methods.